Tag: clinical trial

blog

Amygdalin (Vitamin B17): Cancer Cure or Toxic Myth?

Amygdalin, often called Vitamin B17 or Laetrile, is a compound in apricot kernels and peach pits, promoted as an alternative cancer treatment. This cyanogenic glycoside releases cyanide in the body, which some claim targets cancer cells, inducing apoptosis. However, clinical trials, like those by the National Cancer Institute, show no antitumor benefits, and the FDA […]

blog

EBC-46: Anticancer Power of Blushwood Tree in Cancer Therapy

EBC-46, or tigilanol tiglate, is a promising anticancer compound derived from the seeds of the Blushwood tree in Queensland, Australia. This diterpene ester, discovered by QBiotics, activates protein kinase C to trigger tumor cell death and local inflammation, boosting immune response. Administered via direct injection, it effectively targets solid tumors like melanoma and breast cancer. […]